ADAMTS13 and systemic lupus erythematosus: Serum ADAMTS13 activity was detected by FRET-VWF86 substrate assay in 10 of 32 SLE-TTP patients, all of which were significantly reduced (< 5%), while its inhibitor was detected in all of these patients.